The Peer Perform rating from Wolfe Research suggests that the analyst does not expect significant outperformance or underperformance from Zimmer Biomet Holdings compared to its peers. This neutral rating is likely to result in a stable short-term stock price, as it neither strongly encourages buying nor selling.